Samyukta Mullangi: AI to Support Modern Cancer Care
Samyukta Mullangi, Senior Medical Director at Thyme Care and Medical Oncologist at Tennessee Oncology, shared a post on LinkedIn:
“Everyone I know in medicine is using OpenEvidence, as am I – multiple times a day! But we could argue that OE’s success is not because it has reached a fundamentally new level of agentic cognition.
Rather, it has carefully designed:
– a domain-specific environment (medical and scientific literature)
– restricted source querying (Pubmed and trusted databases, helps limit hallucinations)
– improved user experience (search, summarization, citations -> streamlines trust)
But OE has important gaps. It does not query guidelines or compendia like the NCCN. It does not support more complex queries, including comparative trials and broader evidence synthesis.
In a new op-ed in JAMA Oncology, we argue that guidelines like the NCCN compendia that oncologists use every day to guide their clinical prescribing can benefit from such modernization (query, summarization) alongside choice architecture (nudges, prompt engineering) to influence high-value decision making. Op-ed linked in comments, PDF attached here.
Such improvements would allow these clinical decision support tools to evolve into true copilots that would equip oncologists for the modern era.”
Title: AI to Support Modern Cancer Care – The Augmented Oncologist
Authors: Samyukta Mullangi, Kanan Shah, Debra Patt,
More posts featuring Cancer Care on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023